This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research at U.S. Food and Drug Administration (FDA)

Agenda Sessions

  • Addressing Challenges and Opportunities in Cell and Gene Therapy Development

  • FIRESIDE CHAT ● A Review of Current Priorities for CBER and How the Pandemic is Impacting FDA Resources, Efficiencies and Shifts in Processes